HopeStage
Back to all studies
Not Yet RecruitingNCT06868914

Safety of high-density TMS in healthy adults

About this titleRead the official source — NCT06868914
Device studyAges 22–60United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 22 years to 60 years.

Listed locations
Hartford and 1 more locationSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: November 4, 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
40
Sponsor
National Institute on Drug Abuse (NIDA)
Sponsor type
Research institute
Study type
Device
Intervention type
Device
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 22 Years to 60 Years
Official registry ID
NCT06868914
Official title
Show the full official title

Phase I Clinical Trial to Study the Safety and After-effects of Transcranial Magnetic Stimulation (TMS) Using A High-density Theta Burst Stimulation (hdTBS) Paradigm

Recruitment & locations

Not yet recruiting

Hartford · Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.

Who can participate?

Listed age limits: 22 years to 60 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies